My understanding of this is that it's a mitochondrial uncoupler but with a wide therapeutic window, unlike, say DNP. The problem with DNP is that if you overdose, you're probably screwed. Unless this gets popular in the weight loss circles, it probably won't get studied or popular. It appears to be safe, though. Having lots of (the wrong?) fat in your liver is probably a bad thing metabolically RE: "The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat."
The branded term "Xanthigen" does sound like there could be a conflict of interest in that particular study, as "+" as the study is. Any name is probably an improvement over "Fucowhatever." You can tell the Japanese named it whenever it begins with "F-u." :>
Swanson sells the "Xanthigen" proving it's a trademark and there could be conflict of interest in that study. But it's what I'd buy because it's what was studied.
This could be vaguely related in mechanism: http://news.yale.edu...er-disease-rats. Getting fat out of your liver is probably the best effect of fucoxanthin other than weight loss.
And fucoxanthin sounds a heck of a lot safer than a modified DNP. Actually, that DNP might just be extended-release. Not sure. Maybe others will chime in. I've only bumped into it a few times. A bit surprising, as supplements with the potential to assist in weight loss tend to get a bump in popularity. Maybe it's the terrible name.
Edited by Logjam, 17 April 2016 - 10:14 PM.